4
Changes in Ownership
Aptevo Therapeutics Inc. Filed Acc 0001209191-21-066910
Exit Filing sold 921,336 shares at an average $11.25 ($10,368,236)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −161,336 | $13.52 | $2,181,521 | 760,000 | I |
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −124,509 | $12.45 | $1,550,187 | 635,491 | I |
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −75,491 | $11.74 | $886,430 | 560,000 | I |
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −149,111 | $11.19 | $1,668,433 | 410,889 | I |
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −50,889 | $10.43 | $530,665 | 360,000 | I |
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −200,000 | $10.07 | $2,014,440 | 160,000 | I |
| TANG KEVIN C Exit Filing | 2021-11-23 | Sale | −160,000 | $9.60 | $1,536,560 | 0 | I |
| Open-market sales · 921,336 sh · avg $11.25 · $10,368,236 | |||||||
Loading xslF345X03/doc4.xml…